Embodiments disclosed herein are directed to a catheter placement system with a stiffening system and associated methods thereof. The catheter placement system can include a needle, catheter (e.g. rapid insertion central catheter), one or more guidewires, and a stiffening system, configured to place the catheter while containing portions of the catheter placement system that contact the patient within a sterile environment. Advantageously, the catheter placement system can provide all tools necessary for accessing a vasculature, dilating the insertion site and placing the catheter within a single device, mitigating repeated insertion of multiple tools and reducing the risk of introducing pathogens, or the like. Further, the overall time required to place the catheter is reduced, reducing patient down-time and improving patient outcomes. Advantageously, the stiffening system can support the catheter, or portions thereof disposed outside of the patient. The stiffening system can remain outside of the body as the catheter is placed and allow for more rigid materials to support the catheter.
Disclosed herein is catheter placement system including, a housing defining an interior cavity and configured to maintain a sterile environment therein, a catheter defining a first lumen and including a first section, a second section, and a transition section disposed therebetween, one or both of the transition section and the second section disposed within the sterile environment defined by the housing, and a stiffening system including a first stylet defining a stylet lumen and extending proximally into a proximal portion of the first lumen.
In some embodiments, the catheter placement system further includes a needle extending through a first side port of the catheter into a distal portion of the first lumen, a distal portion of the needle and a distal portion of the first section extending from a distal end of the housing. In some embodiments, the catheter placement system further includes a needle retraction assembly configured to withdraw the needle proximally from the first lumen and dispose the needle in an offset position from an axis of the first lumen within the interior cavity.
In some embodiments, the catheter placement system further includes a first guidewire advancement assembly configured to advance a first guidewire through the first side port of the catheter and through a distal portion of the first lumen. In some embodiments, the catheter placement system further includes a second guidewire assembly including a scroll wheel actuator configured to rotate and advance a second guidewire through the first lumen. In some embodiments, the stiffening system includes a second stylet extending proximally into a proximal portion of a second lumen of the catheter, the second stylet including a stylet guidewire extending distally therefrom into the second section of the catheter.
In some embodiments, the second lumen communicates with a distal opening disposed in a sidewall of the second section, a distal portion of the stylet guidewire configured to selectively occlude the distal opening. In some embodiments, the catheter placement system further includes a catheter advancement assembly configured to advance the catheter distally, and configured to separate a top half of the housing from a bottom half of the housing when advanced to a distal position. In some embodiments, the catheter placement system further includes a manifold including a flushing hub in fluid communication with the stylet lumen, the manifold configured to support the stiffening system. In some embodiments, the catheter placement system further includes a blood flash indicator disposed within the interior cavity and in fluid communication with a lumen of the needle.
Also disclosed is a method of placing a catheter including, providing a catheter placement system having a housing defining a sterile environment and including a needle, a catheter defining a first catheter lumen, and a stiffening system including a stylet having a stylet lumen and in fluid communication with the first catheter lumen, flushing the first catheter lumen by providing a fluid through the stylet lumen, accessing a vasculature of a patient by creating an insertion site with the needle, advancing a first section of the catheter through the insertion site, withdrawing the needle from a lumen of the first section, dilating the insertion site by advancing a transition section of the catheter through the insertion site, advancing a second section of the catheter into the vasculature, and withdrawing the stiffening system from the first catheter lumen.
In some embodiments, the catheter includes the first section disposed at a distal end, the transition section extending proximally from the first section, a second section extending proximally from the transition section, a hub disposed at a proximal end of the second section and an extension set extending proximally from the hub, the extension set including a first extension leg in fluid communication with the first catheter lumen. In some embodiments, the method further includes advancing one of a first guidewire or a second guidewire through a portion of the first lumen into a vasculature of a patient. In some embodiments, advancing the second section of the catheter into the vasculature further includes separating a top half of the housing from a bottom half of the housing.
In some embodiments, the method further includes disengaging the catheter from the catheter placement system by urging the catheter between the top half of the housing and the bottom half of the housing. In some embodiments, the method further includes a manifold having a flushing hub and configured to provide fluid communication between the flushing hub and the stylet lumen. In some embodiments, the method further includes sliding the manifold proximally relative to the housing to withdraw the stiffening system from the first catheter lumen.
In some embodiments, the method further includes actuating a blood flash actuator to provide fluid communication between a lumen of the needle and an interior cavity of a blood flash indicator. In some embodiments, a vacuum is disposed within the interior cavity of the blood flash indicator to draw a fluid flow proximally through the needle lumen.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
In the following description, the terms “or” and “and/or” as used herein are to be interpreted as inclusive or meaning any one or any combination. As an example, “A, B or C” or “A, B and/or C” mean “any of the following, A, B, C, A and B, A and C, B and C, A, B and C.” An exception to this definition will occur only when a combination of elements, components, functions, steps or acts are in some way inherently mutually exclusive.
As shown in
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
The present disclosure generally relates to a catheter placement system (“system”) 100 including a stiffening system, and associated methods thereof. In an embodiment, the catheter placement system 100 can be used to place a catheter, such as for example, a Rapid Insertion Central Catheter (“RICC”) 190 to access a vasculature of a patient. However, it will be appreciated that embodiments disclosed herein can be used to place various catheters, cannulas, single lumen catheters, multi-lumen catheters, intravenous (IV) catheters, peripheral intravenous line (PIV) catheters, peripherally inserted central catheters (PICC), central venous catheter (CVC), dialysis catheters, drainage catheters, and the like, without limitation.
The system 100 generally includes one or more exterior housings, such as a splittable catheter housing (“catheter housing”) 110 and a guidewire housing 120, coupled to a proximal end thereof. The system 100 further includes a needle 140, a catheter 190 such as a Rapid Insertion Central Catheter (RICC), an extension set 180, one or more guidewires 150, 160, and a stiffening system 184, portions of which can be disposed within an interior cavity defined by the one or more exterior housings 110, 120.
In an embodiment, the catheter 190 can include one or more sections configured to display different mechanical properties. For example, the catheter 190 can include a first section 130 disposed at a distally, a second section 170 disposed proximally. The catheter 190 can further include a transition section 136 disposed therebetween, as described in more detail herein. Further, the system 100 can include a first guidewire 150 and a second guidewire 160, as described in more detail herein.
The catheter housing 110 and the guidewire housing 120 can co-operate to define an elongate, cylindrical shape including a tapered distal portion and a substantially circular cross-sectional shape. However, it will be appreciated that other elongate profiles and cross-sectional shapes including triangular, square, hexagonal, polygonal, or combinations thereof, are also contemplated. In an embodiment, a portion of the catheter housing 110 and/or the guidewire housing 120 can define a faceted surface to provide a gripping surface and facilitate manipulation of the system 100. In an embodiment, the catheter housing 110 and/or the guidewire housing 120 can include a protrusion 118 configured to provide an abutment surface for a user to facilitate manipulation of the system 100. In an embodiment, the catheter housing 110 and/or the guidewire housing 120 can be formed of a rigid or semi-rigid material including metal, alloy, polymer, plastic, thermoplastic, elastomer, rubber, silicone rubber, composite, combinations thereof, or the like.
In an embodiment, an outer surface of the catheter housing 110 or the guidewire housing 120 includes a compliant material, elastomer, silicone rubber, or the like, with an increased friction co-efficient, to provide a comfortable gripping surface and facilitate grasping and manipulation of the system 100. In an embodiment, the catheter housing 110 or the guidewire housing 120, or portion thereof, can be formed of a translucent or transparent material to allow a user to observe structures, components, catheters, guidewires, extension sets, elongate medical devices, or the like, disposed therein. As used herein, an “elongate medical device” can include the catheter 190 or portion thereof such as the first section 130 or the second section 170, the needle 140, the first guidewire 150, the second guidewire 160, one or more advancement assemblies, combinations thereof, or the like.
In an embodiment, the catheter housing 110 can include a top housing piece 110A and a bottom housing piece 110B that are releasably engage along a horizontal plane. The top housing piece 110A and the bottom housing piece 110B are configured to selectively detach and disengage from the catheter 190 once the catheter 190 is placed within the vasculature 90 of the patient. In an embodiment, the housing pieces 110A, 110B can be engaged along a longitudinal vertical plane to provide a left housing piece 110A and a right housing piece 110B, or along a plane angled relative to the horizontal or vertical plane.
In an embodiment, a guidewire housing 120 can extend from a proximal end of the catheter housing 110 and define an interior cavity that communicates with an interior cavity of the catheter housing 110. In an embodiment, the guidewire housing 120, or portion thereof, can be formed of a transparent material to allow a user to observe a portion of the catheter 190, the blood flash indicator 122, or an elongate medical device, or the like, disposed therein.
The system 100 can further include an extension set manifold (“manifold”) 182, disposed at a proximal end of the guidewire housing 120 and configured to slide proximally along a longitudinal axis between a distal position (
In an embodiment, the catheter housing 110, guidewire housing 120, and/or one or more barriers, e.g. barriers 114, can define an interior cavity configured to receive one or more elongate medical devices, advancement assemblies, or the like, therein. Advantageously, the interior cavity can maintain the elongate medical devices etc., within a sterile environment, allowing a user to manipulate the system 100 without having to directly contact the elongate medical devices. This maintains the elongate medical device(s) etc. in a sterile environment and mitigates the introduction of pathogens, or similar infection causing agents.
In an embodiment, one or more flexible film barriers can be disposed within the interior cavity of the system 100 to contain one or more elongate medical devices within a sterile environment. For example, as shown in
As shown in
The catheter advancement assembly 174 can be coupled with a catheter actuator 172 disposed on an outer surface of the catheter housing 110. Transitioning the catheter actuator 172 between a proximal position (
In an embodiment, the catheter 190 can further including a hub 192 disposed at a proximal end of the second section 170. The catheter 190 can further include an extension set 180 extending proximally from the hub 192 and comprising one or more extension legs, each communicating with a lumen of the catheter 190. For example, a first extension leg 180A can communicate with a first lumen 194A, a second extension leg 180B can communicate with a second lumen 194B and a third extension leg 180C can communicate with a third lumen 194C. Each extension leg can include a connector such as a luer lock, or the like, disposed at a proximal end thereof. The connector can be configured to couple the extension leg with a syringe, medical fluid line, or the like, to provide fluid communication with a lumen.
In an embodiment, each lumen 194 can communicate with a distal opening 196. For example, the first lumen 194A can extend from the first extension leg 180A, through the hub 192, the second section 170 and the transition section 136, to a first distal opening 196A, disposed at a distal tip of the first section 130. In an embodiment, one of the second lumen 194B or the third lumen 194C can extend from the second extension leg 180B or the third extension leg 180C, respectively, through the hub 192 to the second section 170 and communicate with a respective second distal opening 196B or a third distal opening 196C, disposed in a side wall of the second section 170. In an embodiment, one of the distal openings 196A, 196B, 196C can be disposed in a transition section 136.
In an embodiment, the catheter 190 can include one or more side entry ports (“side ports”) 132, extending through a side wall of one of the first section 130, transition section 136, or second section 170, and communicating with one of the first lumen 194A, second lumen 194B, or third lumen 194C. For example, the first section 130 can include a first side port 132A. A needle 140 or a first guidewire 150 can extend through the first side port 132A, and through a distal portion of the first lumen 194A, through the first distal opening 196A to extend distally of the distal tip of the catheter 190.
In an embodiment, the first section 130 can define a relatively smaller diameter than the second section 170. In an embodiment, the first section 130 can define a relatively more rigid, more resilient, or harder durometer than the second section 170. As such, one or both of the first section 130 and the transition section 136 can provide greater columnar strength relative to the second section 170. In an embodiment, the first section 130 can define a single lumen and define a diameter similar to that of a peripheral intravenous (PIV) catheter. In an embodiment, the second section 170 can define two or more lumen, and define a diameter similar to that of a central venous catheter (CVC). The first section 130 can further include a tapered tip, tapering distally from the diameter of the first section 130 to the diameter of the needle 140, to facilitate insertion of the first section 130 through the access site formed by the needle 140. In an embodiment, the transition section 136 can define a tapered or frusto-conical shape extending from the diameter of the first section 130 to the diameter of the second section 170.
Advantageously, the first section 130 can access a vasculature more easily, due to the relatively smaller diameter. Further, if the incorrect vessel is accessed, removing the first section 130 and closing the access site is more easily achieved due to the smaller size of the access site. If the correct vessel is accessed, the catheter 190 can be urged distally such that the transition section 136 is urged through the access site to dilate the access site from the diameter of the first section 130 to the diameter of the second section 170. The stiffening system 184 can support a portion of the catheter 190, e.g. the second section 170, hub 192, or extension set 180 etc., as the catheter 190 is urged into the vasculature 90. In an embodiment, the catheter 190 or sections thereof can be formed of a plastic, polymer, elastomer, urethane, polyether ether ketone (PEEK), fluorinated ethylene propylene (FEP), or similar suitable material. Advantageously, the stiffening system 184 can be formed of a rigid or resilient material and can support the catheter 190, or sections thereof, which remain outside of the patient as the catheter 190 is advanced into the vasculature. The catheter 190 can be advanced while the stiffening system 184 remains stationary, allowing the stiffening system to support portions of the catheter 190 that remain exterior to the patient. Optionally, the stiffening system 184 can be withdrawn proximally to fully remove the stiffening system 184 from the catheter 190. Since portions of the stiffening system 184, e.g. stylets 186, remain exterior to patient, they can be formed of a more rigid material, and provide greater columnar support to the catheter 190.
The catheter placement system 100 can further include a stiffening system 184 comprising one or more support stylets (“stylets”) 186 extending distally from the manifold 182. In an embodiment, a stylet 186 can further include a guidewire 188 extending from the distal end thereof. As described herein, the stylets 186 remain outside of the patient and can be formed of a substantially rigid or resilient material. The stylet guidewires 188 can be formed of a relatively more flexible material, or display more flexible characteristics relative to the stylets 186. As such, the stiffening system 184 can provide additional support or stiffening properties to the catheter 190 during placement. In an embodiment, one of the stylet(s) 186, and optionally the stylet guidewires 188 remain stationary relative to the system 100 as the catheter 190 is advanced distally. As such the stiffening system 184 is passively withdrawn from the catheter 190 as the catheter 190 is placed, leaving at least the stylets 186 and optionally the stylet guidewires 188 exterior to the patient and supporting portions of the catheter 190 that remain exterior to the patient. As such, the stiffening system 184 can display more rigid mechanical properties and can provide increase columnar support during placement. During placement, or after the catheter 190 has being placed, the stiffening system 184 can be removed proximally.
In an embodiment, the stiffening system 184 can include a first stylet 186A extending distally into the lumen of the first extension leg 180A, i.e. a proximal portion of the first lumen 194A, a second stylet 186B extending distally into the lumen of the second extension leg 180B, and a third stylet 186C extending distally into the lumen of the third extension leg 180C. Further, in an embodiment, one of the second stylet 186B or the third stylet 186C can include a guidewire 188 extending distally therefrom, through the lumen 194 of the hub 192 and the second section 170.
In an embodiment, as shown in
In an embodiment, one or more of the support stylets 186 can define a stylet lumen that is in fluid communication with a lumen of the flushing hub 106. A fluid can be introduced at the flushing hub 106 and pass through the manifold 182, through a lumen of the support stylet 186 and into a lumen 194 of the catheter 190 to flush the catheter 190 and purge the catheter 190 of any gases prior to placement.
With continued reference to
In an embodiment, as shown in
In an embodiment, as shown in
With continued reference to
In an embodiment, the guidewire housing 120 can further include a second guidewire 160 coupled to a second guidewire advancement assembly 164 and slidably or rotatably engaged with the guidewire housing 120. The second guidewire advancement assembly 164 can transition the second guidewire 160 between a retracted position and an extended position. The second guidewire advancement assembly 164 can be coupled with a second guidewire actuator 162 disposed on an outer surface of the guidewire housing 120. In an embodiment, the second guidewire actuator 162 can be a scroll wheel, rotatably coupled with the guidewire housing 120. A portion of the scroll wheel can extend through a side wall of the guidewire housing 120. Rotating the second guidewire actuator 162 can extend or retract the second guidewire 160 along the longitudinal axis.
With continued reference to
In an embodiment, the blood flash indicator 122 can define an interior cavity configured to maintain a vacuum therein. The blood flash indicator 122 can be in fluid communication with a lumen of the needle 140 by way of a communicating tube 124, or similar structure. As a distal tip of the needle 140 accesses a vasculature 90 of the patient, a fluid (e.g. blood) can flow proximally into the blood flash indicator 122 to be observed by a user. In an embodiment, a vacuum disposed within the blood flash indicator 122 can draw a fluid (e.g. blood) proximally through the needle lumen and into the blood flash indicator 122. A user can then observe a color or pulsatile flow characteristics to confirm vascular access. In an embodiment, the system 100 can include a blood flash actuator 126. Actuating the blood flash actuator 126 can open a valve or similar structure to place the vacuum disposed within the blood flash indicator 122, in fluid communication with the needle lumen to draw a fluid proximally therethrough. In an embodiment, the blood flash indicator 122 can further include a pump configured to be actuated by the user to create a vacuum within the blood flash indicator 122. For example, repeatedly actuating the blood flash actuator 126 can actuate the pump and create a vacuum within the blood flash indicator 122 to draw a fluid proximally through the needle lumen.
In an embodiment, the system 100 further includes a cap 108 configured to couple with a distal end of the catheter housing 110 and cover a distal portion of one of the needle 140 or the first section 130 of the catheter 190. The cap 108 can mitigate accidental needle stick injuries during storage or transport and maintains the needle 140, etc. in a sterile environment.
In an exemplary method of use, as shown in
As shown in
As shown in
In an embodiment, with correct vascular access confirmed, a user can actuate the first guidewire actuator 152 to advance the first guidewire 150 through the needle lumen and into the vasculature 90 of the patient until a distal tip of the first guidewire 150 extends distally of the needle tip 141, within the vasculature 90. In an embodiment, a distal tip of the first section 130 can be advanced into the vasculature along with the needle 140, as the needle accesses the vasculature. The distal tip of the first section 130 can be disposed on an outer surface of the needle 140 and can fit tightly therewith to prevent fluids, blood, or tissue from being urged between the needle 140 and first section 130 as the needle access the vasculature.
As shown in
As shown in
As shown in
As shown in
As shown in
As shown in
As shown in
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application claims the benefit of priority to U.S. Provisional Application No. 63/106,792, filed Oct. 28, 2020, which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
1013691 | Shields | Jan 1912 | A |
3225762 | Guttman | Dec 1965 | A |
3382872 | Rubin | May 1968 | A |
3570485 | Reilly | Mar 1971 | A |
3890976 | Bazell et al. | Jun 1975 | A |
4205675 | Vaillancourt | Jun 1980 | A |
4292970 | Hession, Jr. | Oct 1981 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4581019 | Curelaru et al. | Apr 1986 | A |
4594073 | Stine | Jun 1986 | A |
4702735 | Luther et al. | Oct 1987 | A |
4743265 | Whitehouse et al. | May 1988 | A |
4766908 | Clement | Aug 1988 | A |
4863432 | Kvalo | Sep 1989 | A |
4935008 | Lewis, Jr. | Jun 1990 | A |
4950252 | Luther et al. | Aug 1990 | A |
4994040 | Cameron et al. | Feb 1991 | A |
5017259 | Kohsai | May 1991 | A |
5040548 | Yock | Aug 1991 | A |
5057073 | Martin | Oct 1991 | A |
5112312 | Luther | May 1992 | A |
5115816 | Lee | May 1992 | A |
5120317 | Luther | Jun 1992 | A |
5158544 | Weinstein | Oct 1992 | A |
5188593 | Martin | Feb 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5207650 | Martin | May 1993 | A |
RE34416 | Lemieux | Oct 1993 | E |
5267958 | Buchbinder et al. | Dec 1993 | A |
5295970 | Clinton et al. | Mar 1994 | A |
5306247 | Pfenninger | Apr 1994 | A |
5312361 | Zadini et al. | May 1994 | A |
5322512 | Mohiuddin | Jun 1994 | A |
5328472 | Steinke et al. | Jul 1994 | A |
5350358 | Martin | Sep 1994 | A |
5358495 | Lynn | Oct 1994 | A |
5368567 | Lee | Nov 1994 | A |
5378230 | Mahurkar | Jan 1995 | A |
5380290 | Makower et al. | Jan 1995 | A |
5389087 | Miraki | Feb 1995 | A |
5439449 | Mapes et al. | Aug 1995 | A |
5443457 | Ginn et al. | Aug 1995 | A |
5460185 | Johnson et al. | Oct 1995 | A |
5489271 | Andersen | Feb 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5683370 | Luther et al. | Nov 1997 | A |
5713876 | Bogert et al. | Feb 1998 | A |
5718678 | Fleming, III | Feb 1998 | A |
5772636 | Brimhall et al. | Jun 1998 | A |
5885251 | Luther | Mar 1999 | A |
5919164 | Andersen | Jul 1999 | A |
5921971 | Agro et al. | Jul 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5957893 | Luther et al. | Sep 1999 | A |
5971957 | Luther et al. | Oct 1999 | A |
6159198 | Gardeski et al. | Dec 2000 | A |
6206849 | Martin et al. | Mar 2001 | B1 |
6228062 | Howell et al. | May 2001 | B1 |
6475187 | Gerberding | Nov 2002 | B1 |
6551284 | Greenberg et al. | Apr 2003 | B1 |
6606515 | Windheuser et al. | Aug 2003 | B1 |
6616630 | Woehr et al. | Sep 2003 | B1 |
6626869 | Bint | Sep 2003 | B1 |
6638252 | Moulton et al. | Oct 2003 | B2 |
6716228 | Tal | Apr 2004 | B2 |
6726659 | Stocking et al. | Apr 2004 | B1 |
6819951 | Patel et al. | Nov 2004 | B2 |
6821287 | Jang | Nov 2004 | B1 |
6926692 | Katoh et al. | Aug 2005 | B2 |
6962575 | Tal | Nov 2005 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
6994693 | Tal | Feb 2006 | B2 |
6999809 | Currier et al. | Feb 2006 | B2 |
7025746 | Tal | Apr 2006 | B2 |
7029467 | Currier et al. | Apr 2006 | B2 |
7037293 | Carrillo et al. | May 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7094222 | Siekas et al. | Aug 2006 | B1 |
7141050 | Deal et al. | Nov 2006 | B2 |
7144386 | Korkor et al. | Dec 2006 | B2 |
7311697 | Osborne | Dec 2007 | B2 |
7364566 | Elkins et al. | Apr 2008 | B2 |
7377910 | Katoh et al. | May 2008 | B2 |
7390323 | Jang | Jun 2008 | B2 |
D600793 | Bierman et al. | Sep 2009 | S |
D601242 | Bierman et al. | Sep 2009 | S |
D601243 | Bierman et al. | Sep 2009 | S |
7594911 | Powers et al. | Sep 2009 | B2 |
7691093 | Brimhall | Apr 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
D617893 | Bierman et al. | Jun 2010 | S |
D624643 | Bierman et al. | Sep 2010 | S |
7819889 | Healy et al. | Oct 2010 | B2 |
7857788 | Racz | Dec 2010 | B2 |
D630729 | Bierman et al. | Jan 2011 | S |
7909797 | Kennedy, II et al. | Mar 2011 | B2 |
7909811 | Agro et al. | Mar 2011 | B2 |
7922696 | Tal et al. | Apr 2011 | B2 |
7938820 | Webster et al. | May 2011 | B2 |
7967834 | Tal et al. | Jun 2011 | B2 |
7976511 | Fojtik | Jul 2011 | B2 |
7985204 | Katoh et al. | Jul 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8105286 | Anderson et al. | Jan 2012 | B2 |
8192402 | Anderson et al. | Jun 2012 | B2 |
8202251 | Bierman et al. | Jun 2012 | B2 |
8206356 | Katoh et al. | Jun 2012 | B2 |
8361011 | Mendels | Jan 2013 | B2 |
8372107 | Tupper | Feb 2013 | B2 |
8377006 | Tal et al. | Feb 2013 | B2 |
8454577 | Joergensen et al. | Jun 2013 | B2 |
8585858 | Kronfeld et al. | Nov 2013 | B2 |
8657790 | Tal et al. | Feb 2014 | B2 |
8672888 | Tal | Mar 2014 | B2 |
8696645 | Tal et al. | Apr 2014 | B2 |
8784362 | Boutilette et al. | Jul 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8876704 | Golden et al. | Nov 2014 | B2 |
8882713 | Call et al. | Nov 2014 | B1 |
8900192 | Anderson et al. | Dec 2014 | B2 |
8900207 | Uretsky | Dec 2014 | B2 |
8915884 | Tal et al. | Dec 2014 | B2 |
8956327 | Bierman et al. | Feb 2015 | B2 |
9023093 | Pal | May 2015 | B2 |
9067023 | Bertocci | Jun 2015 | B2 |
9126012 | McKinnon et al. | Sep 2015 | B2 |
9138252 | Bierman et al. | Sep 2015 | B2 |
9180275 | Helm | Nov 2015 | B2 |
9265920 | Rundquist et al. | Feb 2016 | B2 |
9272121 | Piccagli | Mar 2016 | B2 |
9445734 | Grunwald | Sep 2016 | B2 |
9522254 | Belson | Dec 2016 | B2 |
9554785 | Walters et al. | Jan 2017 | B2 |
9566087 | Bierman et al. | Feb 2017 | B2 |
9675784 | Belson | Jun 2017 | B2 |
9713695 | Bunch et al. | Jul 2017 | B2 |
9764117 | Bierman et al. | Sep 2017 | B2 |
9770573 | Golden et al. | Sep 2017 | B2 |
9814861 | Boutillette et al. | Nov 2017 | B2 |
9820845 | von Lehe et al. | Nov 2017 | B2 |
9861383 | Clark | Jan 2018 | B2 |
9872971 | Blanchard | Jan 2018 | B2 |
9884169 | Bierman et al. | Feb 2018 | B2 |
9889275 | Voss et al. | Feb 2018 | B2 |
9913585 | McCaffrey et al. | Mar 2018 | B2 |
9913962 | Tal | Mar 2018 | B2 |
9981113 | Bierman | May 2018 | B2 |
10010312 | Tegels | Jul 2018 | B2 |
10065020 | Gaur | Sep 2018 | B2 |
10086170 | Chhikara et al. | Oct 2018 | B2 |
10098724 | Adams et al. | Oct 2018 | B2 |
10111683 | Tsamir et al. | Oct 2018 | B2 |
10118020 | Avneri et al. | Nov 2018 | B2 |
10130269 | McCaffrey et al. | Nov 2018 | B2 |
10220184 | Clark | Mar 2019 | B2 |
10220191 | Belson et al. | Mar 2019 | B2 |
10265508 | Baid | Apr 2019 | B2 |
10271873 | Steingisser et al. | Apr 2019 | B2 |
10376675 | Mitchell et al. | Aug 2019 | B2 |
10675440 | Abitabilo et al. | Jun 2020 | B2 |
10688281 | Blanchard et al. | Jun 2020 | B2 |
10806901 | Burkholz et al. | Oct 2020 | B2 |
10926060 | Stern et al. | Feb 2021 | B2 |
11260206 | Stone et al. | Mar 2022 | B2 |
11400260 | Huang et al. | Aug 2022 | B2 |
11759607 | Biancarelli | Sep 2023 | B1 |
20020040231 | Wysoki | Apr 2002 | A1 |
20020198492 | Miller et al. | Dec 2002 | A1 |
20030036712 | Heh et al. | Feb 2003 | A1 |
20030060863 | Dobak | Mar 2003 | A1 |
20030088212 | Tal | May 2003 | A1 |
20030100849 | Jang | May 2003 | A1 |
20030153874 | Tal | Aug 2003 | A1 |
20030158514 | Tal | Aug 2003 | A1 |
20040015138 | Currier et al. | Jan 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040116864 | Boudreaux | Jun 2004 | A1 |
20040116901 | Appling | Jun 2004 | A1 |
20040167478 | Mooney et al. | Aug 2004 | A1 |
20040193093 | Desmond | Sep 2004 | A1 |
20040230178 | Wu | Nov 2004 | A1 |
20050004554 | Osborne | Jan 2005 | A1 |
20050120523 | Schweikert | Jun 2005 | A1 |
20050131343 | Abrams et al. | Jun 2005 | A1 |
20050215956 | Nerney | Sep 2005 | A1 |
20050245882 | Elkins et al. | Nov 2005 | A1 |
20050283221 | Mann et al. | Dec 2005 | A1 |
20060009740 | Higgins et al. | Jan 2006 | A1 |
20060116629 | Tal et al. | Jun 2006 | A1 |
20060129100 | Tal | Jun 2006 | A1 |
20060129130 | Tal et al. | Jun 2006 | A1 |
20070276288 | Khaw | Nov 2007 | A1 |
20080045894 | Perchik et al. | Feb 2008 | A1 |
20080125744 | Treacy | May 2008 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080132850 | Fumiyama et al. | Jun 2008 | A1 |
20080262430 | Anderson et al. | Oct 2008 | A1 |
20080262431 | Anderson et al. | Oct 2008 | A1 |
20080294111 | Tal et al. | Nov 2008 | A1 |
20080312578 | DeFonzo et al. | Dec 2008 | A1 |
20080319387 | Amisar et al. | Dec 2008 | A1 |
20090187147 | Kurth et al. | Jul 2009 | A1 |
20090221961 | Tal | Sep 2009 | A1 |
20090270889 | Tal et al. | Oct 2009 | A1 |
20090292272 | McKinnon | Nov 2009 | A1 |
20100030154 | Duffy | Feb 2010 | A1 |
20100256487 | Hawkins et al. | Oct 2010 | A1 |
20100298839 | Castro | Nov 2010 | A1 |
20100305474 | DeMars et al. | Dec 2010 | A1 |
20110004162 | Tal | Jan 2011 | A1 |
20110009827 | Bierman et al. | Jan 2011 | A1 |
20110021994 | Anderson et al. | Jan 2011 | A1 |
20110066142 | Tal et al. | Mar 2011 | A1 |
20110071502 | Asai | Mar 2011 | A1 |
20110144620 | Tal | Jun 2011 | A1 |
20110152836 | Riopelle et al. | Jun 2011 | A1 |
20110190778 | Arpasi | Aug 2011 | A1 |
20110202006 | Bierman et al. | Aug 2011 | A1 |
20110251559 | Tal et al. | Oct 2011 | A1 |
20110270192 | Anderson et al. | Nov 2011 | A1 |
20120041371 | Tal et al. | Feb 2012 | A1 |
20120065590 | Bierman et al. | Mar 2012 | A1 |
20120078231 | Hoshinouchi | Mar 2012 | A1 |
20120130411 | Tal et al. | May 2012 | A1 |
20120130415 | Tal et al. | May 2012 | A1 |
20120157854 | Kurrus et al. | Jun 2012 | A1 |
20120215171 | Christiansen | Aug 2012 | A1 |
20120220942 | Hall et al. | Aug 2012 | A1 |
20120226239 | Green | Sep 2012 | A1 |
20120283640 | Anderson et al. | Nov 2012 | A1 |
20120316500 | Bierman et al. | Dec 2012 | A1 |
20130053763 | Makino et al. | Feb 2013 | A1 |
20130053826 | Shevgoor | Feb 2013 | A1 |
20130123704 | Bierman et al. | May 2013 | A1 |
20130158338 | Kelly et al. | Jun 2013 | A1 |
20130188291 | Vardiman | Jul 2013 | A1 |
20130237931 | Tal et al. | Sep 2013 | A1 |
20130306079 | Tracy | Nov 2013 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140081210 | Bierman et al. | Mar 2014 | A1 |
20140094774 | Blanchard | Apr 2014 | A1 |
20140100552 | Gallacher et al. | Apr 2014 | A1 |
20140207052 | Tal et al. | Jul 2014 | A1 |
20140207069 | Bierman et al. | Jul 2014 | A1 |
20140214005 | Belson | Jul 2014 | A1 |
20140257111 | Yamashita et al. | Sep 2014 | A1 |
20140276432 | Bierman et al. | Sep 2014 | A1 |
20140276599 | Cully et al. | Sep 2014 | A1 |
20150011834 | Ayala et al. | Jan 2015 | A1 |
20150080939 | Adams et al. | Mar 2015 | A1 |
20150094653 | Pacheco et al. | Apr 2015 | A1 |
20150112307 | Margolis | Apr 2015 | A1 |
20150112310 | Call et al. | Apr 2015 | A1 |
20150126930 | Bierman et al. | May 2015 | A1 |
20150148595 | Bagwell et al. | May 2015 | A1 |
20150190168 | Bierman et al. | Jul 2015 | A1 |
20150196210 | McCaffrey et al. | Jul 2015 | A1 |
20150224287 | Bian et al. | Aug 2015 | A1 |
20150231364 | Blanchard | Aug 2015 | A1 |
20150283357 | Lampropoulos et al. | Oct 2015 | A1 |
20150297868 | Tal et al. | Oct 2015 | A1 |
20150320969 | Haslinger et al. | Nov 2015 | A1 |
20150320977 | Vitullo et al. | Nov 2015 | A1 |
20150351793 | Bierman et al. | Dec 2015 | A1 |
20150359549 | Lenker et al. | Dec 2015 | A1 |
20150359998 | Carmel et al. | Dec 2015 | A1 |
20160082223 | Barnell | Mar 2016 | A1 |
20160114124 | Tal | Apr 2016 | A1 |
20160158523 | Helm | Jun 2016 | A1 |
20160220786 | Mitchell | Aug 2016 | A1 |
20160242661 | Fischell et al. | Aug 2016 | A1 |
20160256101 | Aharoni et al. | Sep 2016 | A1 |
20160325073 | Davies et al. | Nov 2016 | A1 |
20160331938 | Blanchard et al. | Nov 2016 | A1 |
20160338728 | Tal | Nov 2016 | A1 |
20160346503 | Jackson et al. | Dec 2016 | A1 |
20170035990 | Swift | Feb 2017 | A1 |
20170072165 | Lim et al. | Mar 2017 | A1 |
20170120000 | Osypka et al. | May 2017 | A1 |
20170120014 | Harding et al. | May 2017 | A1 |
20170120034 | Kaczorowski | May 2017 | A1 |
20170128700 | Roche Rebollo | May 2017 | A1 |
20170156987 | Babbs et al. | Jun 2017 | A1 |
20170172653 | Urbanski et al. | Jun 2017 | A1 |
20170182293 | Chhikara et al. | Jun 2017 | A1 |
20170239443 | Abitabilo et al. | Aug 2017 | A1 |
20170259043 | Chan et al. | Sep 2017 | A1 |
20170273713 | Shah et al. | Sep 2017 | A1 |
20170296792 | Ornelas Vargas et al. | Oct 2017 | A1 |
20170326339 | Bailey et al. | Nov 2017 | A1 |
20170361070 | Hivert | Dec 2017 | A1 |
20170368255 | Provost et al. | Dec 2017 | A1 |
20180001062 | O'Carrol et al. | Jan 2018 | A1 |
20180021545 | Mitchell et al. | Jan 2018 | A1 |
20180116690 | Sarabia et al. | May 2018 | A1 |
20180117284 | Appling et al. | May 2018 | A1 |
20180133438 | Hulvershorn et al. | May 2018 | A1 |
20180154062 | DeFonzo et al. | Jun 2018 | A1 |
20180154112 | Chan et al. | Jun 2018 | A1 |
20180214674 | Ebnet et al. | Aug 2018 | A1 |
20180296799 | Horst et al. | Oct 2018 | A1 |
20180296804 | Bierman | Oct 2018 | A1 |
20180310955 | Lindekugel et al. | Nov 2018 | A1 |
20190015646 | Matlock et al. | Jan 2019 | A1 |
20190021640 | Burkholz et al. | Jan 2019 | A1 |
20190060616 | Solomon | Feb 2019 | A1 |
20190076167 | Fantuzzi et al. | Mar 2019 | A1 |
20190134349 | Cohn et al. | May 2019 | A1 |
20190192824 | Cordeiro et al. | Jun 2019 | A1 |
20190201665 | Turpin | Jul 2019 | A1 |
20190209812 | Burkholz et al. | Jul 2019 | A1 |
20190255294 | Mitchell et al. | Aug 2019 | A1 |
20190255298 | Mitchell et al. | Aug 2019 | A1 |
20190275303 | Tran et al. | Sep 2019 | A1 |
20190276268 | Akingba | Sep 2019 | A1 |
20190321590 | Burkholz et al. | Oct 2019 | A1 |
20190351196 | Ribelin et al. | Nov 2019 | A1 |
20200001051 | Huang et al. | Jan 2020 | A1 |
20200016374 | Burkholz et al. | Jan 2020 | A1 |
20200046948 | Burkholz et al. | Feb 2020 | A1 |
20200100716 | Devgon et al. | Apr 2020 | A1 |
20200129732 | Vogt et al. | Apr 2020 | A1 |
20200147349 | Holt | May 2020 | A1 |
20200197682 | Franklin et al. | Jun 2020 | A1 |
20200197684 | Wax | Jun 2020 | A1 |
20200237278 | Asbaghi | Jul 2020 | A1 |
20200359995 | Walsh et al. | Nov 2020 | A1 |
20210030944 | Cushen et al. | Feb 2021 | A1 |
20210060306 | Kumar | Mar 2021 | A1 |
20210069471 | Howell | Mar 2021 | A1 |
20210085927 | Howell | Mar 2021 | A1 |
20210100985 | Akcay et al. | Apr 2021 | A1 |
20210113809 | Howell | Apr 2021 | A1 |
20210113810 | Howell | Apr 2021 | A1 |
20210113816 | DiCianni | Apr 2021 | A1 |
20210121661 | Howell | Apr 2021 | A1 |
20210121667 | Howell | Apr 2021 | A1 |
20210228842 | Scherich et al. | Jul 2021 | A1 |
20210228843 | Howell et al. | Jul 2021 | A1 |
20210244920 | Kujawa | Aug 2021 | A1 |
20210290898 | Burkholz | Sep 2021 | A1 |
20210290901 | Burkholz et al. | Sep 2021 | A1 |
20210290913 | Horst et al. | Sep 2021 | A1 |
20210322729 | Howell | Oct 2021 | A1 |
20210330941 | Howell et al. | Oct 2021 | A1 |
20210330942 | Howell | Oct 2021 | A1 |
20210361915 | Howell et al. | Nov 2021 | A1 |
20210402149 | Howell | Dec 2021 | A1 |
20210402153 | Howell et al. | Dec 2021 | A1 |
20220001138 | Howell | Jan 2022 | A1 |
20220032013 | Howell et al. | Feb 2022 | A1 |
20220032014 | Howell et al. | Feb 2022 | A1 |
20220062528 | Thornley et al. | Mar 2022 | A1 |
20220062596 | Ribelin et al. | Mar 2022 | A1 |
20220193376 | Spataro et al. | Jun 2022 | A1 |
20220193377 | Haymond et al. | Jun 2022 | A1 |
20220193378 | Spataro et al. | Jun 2022 | A1 |
20220323723 | Spataro et al. | Oct 2022 | A1 |
20220331562 | Jaros et al. | Oct 2022 | A1 |
20220331563 | Papadia | Oct 2022 | A1 |
20230042898 | Howell et al. | Feb 2023 | A1 |
20230096377 | West et al. | Mar 2023 | A1 |
20230096740 | Bechstein et al. | Mar 2023 | A1 |
20230099654 | Blanchard et al. | Mar 2023 | A1 |
20230100482 | Howell | Mar 2023 | A1 |
20230101455 | Howell et al. | Mar 2023 | A1 |
20230102231 | Bechstein et al. | Mar 2023 | A1 |
20230173231 | Parikh et al. | Jun 2023 | A1 |
20230233814 | Howell et al. | Jul 2023 | A1 |
20230381459 | Belson et al. | Nov 2023 | A1 |
20240009427 | Howell et al. | Jan 2024 | A1 |
20240050706 | Howell et al. | Feb 2024 | A1 |
20240198058 | Howell et al. | Jun 2024 | A1 |
Number | Date | Country |
---|---|---|
202012006191 | Jul 2012 | DE |
0653220 | May 1995 | EP |
0730880 | Sep 1996 | EP |
2061385 | May 2009 | EP |
1458437 | Mar 2010 | EP |
2248549 | Nov 2010 | EP |
2319576 | May 2011 | EP |
2366422 | Sep 2011 | EP |
2486880 | Aug 2012 | EP |
2486881 | Aug 2012 | EP |
2486951 | Aug 2012 | EP |
2512576 | Oct 2012 | EP |
2152348 | Feb 2015 | EP |
3473291 | Apr 2019 | EP |
3093038 | May 2019 | EP |
2260897 | Sep 2019 | EP |
3693051 | Aug 2020 | EP |
1273547 | May 1972 | GB |
2004248987 | Sep 2004 | JP |
2008054859 | Mar 2008 | JP |
9421315 | Sep 1994 | WO |
9532009 | Nov 1995 | WO |
9844979 | Oct 1998 | WO |
9853871 | Dec 1998 | WO |
9857685 | Dec 1998 | WO |
9912600 | Mar 1999 | WO |
9926681 | Jun 1999 | WO |
0006221 | Feb 2000 | WO |
0054830 | Sep 2000 | WO |
2003008020 | Jan 2003 | WO |
2003057272 | Jul 2003 | WO |
03068073 | Aug 2003 | WO |
2003066125 | Aug 2003 | WO |
2005096778 | Oct 2005 | WO |
2006055288 | May 2006 | WO |
2006055780 | May 2006 | WO |
2007046850 | Apr 2007 | WO |
2008033983 | Mar 2008 | WO |
2008092029 | Jul 2008 | WO |
2008131300 | Oct 2008 | WO |
2008131289 | Oct 2008 | WO |
2009114833 | Sep 2009 | WO |
2009114837 | Sep 2009 | WO |
2010048449 | Apr 2010 | WO |
2010056906 | May 2010 | WO |
2010083467 | Jul 2010 | WO |
2010132608 | Nov 2010 | WO |
2011081859 | Jul 2011 | WO |
2011097639 | Aug 2011 | WO |
2011109792 | Sep 2011 | WO |
2011146764 | Nov 2011 | WO |
2012068162 | May 2012 | WO |
2012068166 | May 2012 | WO |
2012135761 | Oct 2012 | WO |
2012154277 | Nov 2012 | WO |
2012162677 | Nov 2012 | WO |
2013026045 | Feb 2013 | WO |
2013138519 | Sep 2013 | WO |
2014006403 | Jan 2014 | WO |
2014100392 | Jun 2014 | WO |
2014113257 | Jul 2014 | WO |
2014152005 | Sep 2014 | WO |
2014197614 | Dec 2014 | WO |
2015057766 | Apr 2015 | WO |
2015077560 | May 2015 | WO |
2015168655 | Nov 2015 | WO |
2016110824 | Jul 2016 | WO |
2016123278 | Aug 2016 | WO |
2016139590 | Sep 2016 | WO |
2016139597 | Sep 2016 | WO |
2016178974 | Nov 2016 | WO |
2016187063 | Nov 2016 | WO |
2016176065 | Nov 2016 | WO |
2018089275 | May 2018 | WO |
2018089285 | May 2018 | WO |
2018089385 | May 2018 | WO |
2018191547 | Oct 2018 | WO |
2018213148 | Nov 2018 | WO |
2018218236 | Nov 2018 | WO |
2019050576 | Mar 2019 | WO |
2019146026 | Aug 2019 | WO |
2019199734 | Oct 2019 | WO |
2020014149 | Jan 2020 | WO |
2020069395 | Apr 2020 | WO |
2020109448 | Jun 2020 | WO |
2020113123 | Jun 2020 | WO |
2021038041 | Mar 2021 | WO |
2021050302 | Mar 2021 | WO |
2021077103 | Apr 2021 | WO |
2021062023 | Apr 2021 | WO |
2021081205 | Apr 2021 | WO |
2021086793 | May 2021 | WO |
2021236950 | Nov 2021 | WO |
2021226050 | Nov 2021 | WO |
2022031618 | Feb 2022 | WO |
2022094141 | May 2022 | WO |
2022133297 | Jun 2022 | WO |
2022-140406 | Jun 2022 | WO |
2022140429 | Jun 2022 | WO |
2022217098 | Oct 2022 | WO |
2023014994 | Feb 2023 | WO |
2023049498 | Mar 2023 | WO |
2023049505 | Mar 2023 | WO |
2023049511 | Mar 2023 | WO |
2023049519 | Mar 2023 | WO |
2023049522 | Mar 2023 | WO |
2023146792 | Aug 2023 | WO |
Entry |
---|
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Board Decision dated Oct. 30, 2023. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Aug. 9, 2023. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Non-Final Office Action dated Jul. 27, 2023. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Notice of Allowance dated Oct. 27, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Non-Final Office Action dated Oct. 4, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Oct. 13, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Jul. 27, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Nov. 21, 2023. |
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Nov. 3, 2023. |
PCT/US2020/052536 filed Sep. 24, 2020 International Search Report and Written Opinion dated Dec. 4, 2020. |
PCT/US2021/014700 filed Jan. 22, 2021 International Search Report and Written Opinion dated Jun. 29, 2021. |
PCT/US2021/028018 filed Apr. 19, 2021 International Search Report and Written Opinion dated Sep. 13, 2021. |
PCT/US2021/028683 filed Apr. 22, 2021 International Search Report and Written Opinion dated Sep. 16, 2021. |
PCT/US2021/029183 filed Apr. 26, 2021 International Search Report and Written Opinion dated Sep. 24, 2021. |
PCT/US2021/033443 filed May 20, 2021 International Search Report and Written Opinion dated Sep. 23, 2021. |
PCT/US2021/039084 filed Jun. 25, 2021 International Search Report and Written Opinion dated Jan. 10, 2022. |
PCT/US2021/044029 filed Jul. 30, 2021 International Search Report and Written Opinion dated Dec. 9, 2021. |
PCT/US2021/044223 filed Aug. 2, 2021 International Search Report and Written Opinion dated Dec. 21, 2021. |
PCT/US2021/048275 filed Aug. 30, 2021 International Search Report and Written Opinion dated Jan. 4, 2022. |
PCT/US2021/064642 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 11, 2022. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Final Office Action dated May 30, 2018. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Jan. 25, 2019. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Nov. 2, 2017. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Notice of Allowance dated May 15, 2019. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Final Office Action dated Jan. 25, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated May 11, 2021. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Non-Final Office Action dated May 11, 2022. |
PCT/US2021/057135 filed Oct. 28, 2021 International Preliminary Report on Patentability dated May 2, 2023. |
PCT/US2021/057135 filed Oct. 28, 2021 International Search Report and Written Opinion dated Mar. 11, 2022. |
PCT/US2023/011173 filed Jan. 19, 2023 International Search Report and Written Opinion dated May 22, 2023. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 8, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Notice of Allowance dated Jul. 3, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Restriction Requirement dated Jun. 7, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Restriction Requirement dated Jul. 20, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Jul. 17, 2023. |
PCT/US2021/064671 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 27, 2022. |
PCT/US2022/024085 filed Apr. 8, 2022 International Search Report and Wirtten Opinion dated Sep. 12, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Examiner's Answer dated Oct. 31, 2022. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Notice of Allowance dated Sep. 16, 2022. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Non-Final Office Action dated Oct. 25, 2022. |
PCT/US2022/039614 filed Aug. 5, 2022 International Search Report and Written Opinion dated Dec. 22, 2022. |
PCT/US2022/044848 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 3, 2023. |
PCT/US2022/044879 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044901 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044918 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 21, 2023. |
PCT/US2022/044923 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 15, 2023. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Apr. 24, 2023. |
U.S. Appl. No. 17/237,909, filed Apr. 22, 2021 Restriction Requirement dated Feb. 1, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Non-Final Office Action dated Jan. 26, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Mar. 2, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Restriction Requirement dated Mar. 30, 2023. |
PCT/US2021/028018 filed Apr. 19, 2021 International Preliminary Report on Patentability dated Jun. 3, 2022. |
PCT/US2021/064174 filed Dec. 17, 2021 International Search Report and Written Opinion dated May 18, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated Jan. 18, 2024. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Restriction Requirement dated Jan. 18, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Advisory Action dated Feb. 22, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Dec. 6, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Final Office Action dated Mar. 13, 2024. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Feb. 14, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Dec. 1, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Advisory Action dated Feb. 14, 2024. |
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Final Office Action dated Feb. 29, 2024. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Final Office Action dated Sep. 20, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Aug. 14, 2024. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Notice of Allowance dated Jul. 17, 2024. |
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Notice of Allowance dated Jul. 24, 2024. |
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Aug. 20, 2024. |
U.S. Appl. No. 17/558,124, filed Dec. 21, 2021 Non-Final Office Action dated Sep. 20, 2024. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Notice of Allowance dated May 20, 2024. |
U.S. Appl. No. 17/234,611, filed Apr. 19, 2021 Non-Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 4, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated May 6, 2024. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Jul. 5, 2024. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/554,978, filed Dec. 17, 2021 Non-Final Office Action dated Apr. 19, 2024. |
Number | Date | Country | |
---|---|---|---|
20220126064 A1 | Apr 2022 | US |
Number | Date | Country | |
---|---|---|---|
63106792 | Oct 2020 | US |